SAR 31.95
(2.4%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 129.2 Million SAR | 33.64% |
2022 | 96.67 Million SAR | 56.94% |
2021 | 61.6 Million SAR | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | 49.35 Million SAR | 5.71% |
2023 Q2 | 53.04 Million SAR | -0.25% |
2023 Q4 | 46.68 Million SAR | -11.98% |
2023 FY | 129.2 Million SAR | 33.64% |
2022 Q2 | 43.5 Million SAR | 0.0% |
2022 FY | 96.67 Million SAR | 56.94% |
2022 Q4 | 53.17 Million SAR | 22.24% |
2021 FY | 61.6 Million SAR | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Middle East Pharmaceutical Industries Co. | 207.04 Million SAR | 37.595% |
Al-Dawaa Medical Services Company | 2.06 Billion SAR | 93.742% |
Nahdi Medical Company | 3.52 Billion SAR | 96.332% |
Al-Razi Medical Co. | 14.07 Million SAR | -818.059% |